“Dose Reduction of Ibrutinib in Chronic Lymphocytic Leukemia: Long-Term Outcomes from a Real-World Single-Center Experience”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 18, no. 1, Oct. 2026, p. e2026090, https://doi.org/10.4084/MJHID.2026.090.